NCT06504719 2025-09-15Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab GovitecanHellenic Cooperative Oncology GroupCompleted312 enrolled
NCT06991790 2025-05-28Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker ExplorationPeking University Cancer Hospital & InstituteRecruiting51 enrolled